SUSQUEHANNA INTERNATIONAL GROUP, LLP - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$239,241
-96.5%
37,265
-96.0%
0.00%
-100.0%
Q1 2023$6,894,007
+118.7%
925,370
+28.3%
0.00%0.0%
Q4 2022$3,151,644
-12.1%
721,200
+13.0%
0.00%0.0%
Q3 2022$3,586,000
-31.7%
638,000
-29.9%
0.00%0.0%
Q2 2022$5,249,000
-40.5%
909,700
+4.5%
0.00%0.0%
Q1 2022$8,827,000
-31.5%
870,500
-44.1%
0.00%
Q4 2021$12,894,0001,557,2000.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 750,000$7,605,0008.16%
K.J. Harrison & Partners Inc 1,351,782$13,749,0002.21%
Redmond Asset Management, LLC 137,942$1,399,0000.42%
SABBY MANAGEMENT, LLC 29,962$304,0000.04%
Concord Wealth Partners 16,775$170,0000.04%
Leonard Green & Partners, L.P. 500,000$5,070,0000.04%
Summit Trail Advisors, LLC 35,000$355,0000.03%
WASATCH ADVISORS LP 244,691$2,481,0000.01%
Apollon Wealth Management, LLC 13,900$141,0000.01%
NATIONAL BANK OF CANADA /FI/ 156,900$1,591,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders